Women struggling with hair loss can now get Topical Finasteride & Minoxidil Spray and Oral Spironolactone via Hers‘ telemedicine platform. The company also offers a range of other hair health related products including stand-alone Minoxidil 5% foam and Minoxidil 2% topical solution hair regrowth treatments, biotin gummies to support healthy hair, thickening shampoo and conditioner, as well as repairing hair masks and a cleansing scalp scrub. To help with product selection and personalize the experience the company also offers a hair care assessment tool, which provides users with a custom hair care routine based on answers provided to a few hair related questions.
Why it matters
Hair loss affects around 1 in 3 women, so roughly 30 million in the U.S. alone, at some point in their lives. In recent years, medical experts have seen an increase in patients across the country suffering from stress-related hair loss. Internet searches alone for hair loss have increased by 8 percent in the 12 months since February 2021.
On the record
Hilary Coles, Co-founder and SVP of Brand & Innovation at Hims & Hers explains: “This launch is the direct result of Hers’ close relationship with our consumers, listening to their health goals and what they feel is missing from the hair loss market. Our ability to continue to bring clinically-proven ingredients to market in a unique dosage form through innovative compounding preparations remains unparalleled. We’ve made it our mission to destigmatize issues like hair loss so that women aren’t embarrassed to confidently take control of their health!”
